![Introduction to Regulatory Affairs: 3. Roles of the European Directorate for the Quality of Medicines (EDQM) and the European Pharmacopoeia (EP) Commission in the medicines regulations system Introduction to Regulatory Affairs: 3. Roles of the European Directorate for the Quality of Medicines (EDQM) and the European Pharmacopoeia (EP) Commission in the medicines regulations system](https://learning.eupati.eu/pluginfile.php/1435/mod_page/content/9/afbeelding.png)
Introduction to Regulatory Affairs: 3. Roles of the European Directorate for the Quality of Medicines (EDQM) and the European Pharmacopoeia (EP) Commission in the medicines regulations system
![Emission reductions in 2030 relative to 2005 for the REF and CEP scenarios ( EU-28) — European Environment Agency Emission reductions in 2030 relative to 2005 for the REF and CEP scenarios ( EU-28) — European Environment Agency](https://www.eea.europa.eu/data-and-maps/figures/emission-reductions-in-2030-relative/emission-reductions-in-2030-relative/Fig8.3-103285-Emission-reduction.eps.75dpi.png/at_download/image)
Emission reductions in 2030 relative to 2005 for the REF and CEP scenarios ( EU-28) — European Environment Agency
![Europe - Implementation of the European Pharmacopoeia Supplement 10.6 – Notification for CEP holders - RIS.WORLD Europe - Implementation of the European Pharmacopoeia Supplement 10.6 – Notification for CEP holders - RIS.WORLD](https://www.ris.world/wp-content/uploads/2019/06/edqm.png)